About
Team
Portfolio
News
Contact

Investors Login

Investors Login

Attovia Therapeutics Launches With $60 Million Series A Financing To Unlock Potential Of Novel Biparatopic Nanobody Platform

Attovia Therapeutics Launches With $60 Million Series A Financing To Unlock Potential Of Novel Biparatopic Nanobody Platform

Copyright 2023 IIF Management Company LLC. All rights reserved. “Illumina” and “Illumina Ventures” are trademarks of Illumina, Inc. and are used herein with their permission. All other company names, logos, and other trademarks are the property of their respective owners.